Company Profile
Established on Mar.,2013,with an initial registered capital of 1 million RMB, Baizhaishan Pharmaceuticals Co.,Ltd.is dedicated in providing regulatory R&D, manufacturing and marketing of microbial/chemical drug products, drug substances and intermediates.The company is located inChengdu Economic Development Zone.We have a technicalteam of 1 PhD (graduated from US universities),3 MS and 5 BS. With comprehensive knowledge in technical science and regulations, Baizhaishan is capable of providing high quality products to fulfill regulatory requirement of local Agencies, domestic (sFDA) or abroad(US FDA,EU EMEA or JP PMDA).At the very beginning of the establishment of Baizhaishan, long-term product orders were signed for several microbial intermediate with a US client.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
1,4-Dihydro-1,4-epoxynaphthalene |
1,4-Epoxynaphthalene,1,4-dihydro-;1,4-Dihydro-1,4-epoxynaphthalene;1,4-Dihydronaphthalene-1,4-endo-oxide;1,4-Epoxy-1,4-dihydronaphthalene;7-Oxabenzonorbornadiene;1,4-Dihydronaphthalene-1,4-oxide;1,4-Dihydronaphthalene-1,4-epoxide;NSC 101863;Benzooxanorbornadiene;914300-18-8 |
573-57-9 | Inquiry | |
1,4-Thioxane-1,1-dioxide |
1,4-Oxathiane,4,4-dioxide;p-Thioxane sulfone;Thioxane sulfone;Oxathiane 4,4-dioxide;1,4-Thioxan-1,1-dioxide;1,4-Thioxane-1,1-dioxide;NSC 39595;1,4-Oxathiane sulfone;1,4λ6-Oxathiane-4,4-dione |
107-61-9 | Inquiry | |
2-Bromoterephthalic acid |
1,4-Benzenedicarboxylic acid,2-bromo-;Terephthalic acid,bromo-;2-Bromo-1,4-benzenedicarboxylic acid;2-Bromoterephthalic acid;Bromoterephthalic acid;NSC 3985 |
586-35-6 | Inquiry | |
2-Methylcinnamic acid |
2-Propenoic acid,3-(2-methylphenyl)-;Cinnamic acid,o-methyl-;3-(2-Methylphenyl)-2-propenoic acid;o-Methylcinnamic acid;2-Methylcinnamic acid;NSC 99069;3-(2-Methylphenyl)acrylic acid |
2373-76-4 | Inquiry | |
Epirubicin hydrochloride |
5,12-Naphthacenedione,10-[(3-amino-2,3,6-trideoxy-α-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-,hydrochloride (1:1),(8S,10S)-;5,12-Naphthacenedione,10-[(3-amino-2,3,6-trideoxy-α-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-,hydrochloride,(8S-cis)-;5,12-Naphthacenedione,10-[(3-amino-2,3,6-trideoxy-α-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-,hydrochloride,(8S,10S)-;4′-epi-Adriamycin hydrochloride;4′-Epidoxorubicin hydrochloride;Epirubicin hydrochloride;Farmorubicin;Pharmorubicin;Epidoxorubicin hydrochloride;Ellence |
56390-09-1 | - / 99% | Inquiry |
Imatinibmesylate & its intermediates |
Benzamide,4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-,methanesulfonate (1:1);Benzamide,4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-,monomethanesulfonate;Imatinib mesilate;Imatinib mesylate;CGP 57148B;STI 571;Glivec;Gleevac;Gleevec;1-Methyl-4-(4-((4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)carbamoyl)benzyl)piperazine methanesulfonate;Mitinab;ST 571 |
220127-57-1 | - / 99% | Inquiry |
O-Benzyl-D-tyrosine |
H-D-TYR(BZL)-OH;H-D-TYR-OBZL;D-TYROSINE BENZYL ESTER;D-TYROSINE BENZYL ETHER;D-TYROSINE(BZL)-OH;(R)-2-AMINO-3-(4-BENZYLOXYPHENYL)PROPANOIC ACID;O-BENZYL-D-TYR;O-BENZYL-D-TYROSINE |
65733-15-5 | Inquiry | |
O-Benzyl-L-tyrosine |
L-Tyrosine,O-(phenylmethyl)-;Alanine,3-[p-(benzyloxy)phenyl]-,L-;O-(Phenylmethyl)-L-tyrosine;O-Benzyltyrosine;O-Benzyl-L-tyrosine;Tyrosine benzyl ether;NSC 163630;(S)-2-Amino-3-[4-(benzyloxy)phenyl]propanoic acid;(2S)-2-Amino-3-[4-(benzyloxy)phenyl]propanoic acid;(2S)-2-Amino-3-(4-phenylmethoxyphenyl)propanoic acid;1681057-92-0;1881273-61-5 |
16652-64-5 | Inquiry |